
Persistent Systems Limited has informed the Exchange regarding a press release dated March 17, 2026, titled "Persistent Launches AI-Powered Generative Molecules and Virtual Screening Solution Powered by NVIDIA".
Filed with NSE · · 4 pages · English
Persistent Systems Limited has issued a press release announcing the launch of an AI-powered generative molecules and virtual screening solution in collaboration with NVIDIA. This solution aims to enhance early-stage drug discovery by leveraging NVIDIA's BioNeMo Framework and advanced AI technologies. The collaboration is designed to help healthcare and life sciences organizations accelerate drug discovery processes and improve research outcomes. Persistent's new solution will enable high-fidelity molecular simulations and streamline workflows in drug discovery, reducing the time from experimentation to production.
Written by 6ix AI from the company’s filing. How 6ix writes summaries

Persistent Systems Limited has informed the Exchange regarding a press release dated March 17, 2026, titled "Persistent Launches AI-Powered Generative Molecules and Virtual Screening Solution Powered by NVIDIA".
Persistent Systems Limited on 6ix
Follow Persistent Systems into a list and get an email when it puts out news.
Follow Persistent Systems